These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23097176)

  • 1. Challenges for academic drug discovery.
    Jorgensen WL
    Angew Chem Int Ed Engl; 2012 Nov; 51(47):11680-4. PubMed ID: 23097176
    [No Abstract]   [Full Text] [Related]  

  • 2. The time is now.
    Nat Rev Drug Discov; 2005 Aug; 4(8):613. PubMed ID: 16106580
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug discovery in academia.
    Verkman AS
    Am J Physiol Cell Physiol; 2004 Mar; 286(3):C465-74. PubMed ID: 14761879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative business models for drug discovery.
    Bunin BA; Ekins S
    Drug Discov Today; 2011 Aug; 16(15-16):643-5. PubMed ID: 21745585
    [No Abstract]   [Full Text] [Related]  

  • 5. Case study: technology initiative led to advanced lead optimization screening processes at Bristol-Myers Squibb, 2004-2009.
    Zhang L; Cvijic ME; Lippy J; Myslik J; Brenner SL; Binnie A; Houston JG
    Drug Discov Today; 2012 Jul; 17(13-14):733-40. PubMed ID: 22425710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical drug discovery research and training at Vanderbilt.
    Lindsley CW; Weaver D; Jones C; Marnett L; Conn PJ
    ACS Chem Biol; 2007 Jan; 2(1):17-20. PubMed ID: 17243778
    [No Abstract]   [Full Text] [Related]  

  • 9. Using label-free screening technology to improve efficiency in drug discovery.
    Halai R; Cooper MA
    Expert Opin Drug Discov; 2012 Feb; 7(2):123-31. PubMed ID: 22468914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIPTE: a multi-university partnership supporting academic drug development.
    Gurvich VJ; Byrn SR
    Drug Discov Today; 2013 Oct; 18(19-20):916-21. PubMed ID: 23732177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-based drug design - tools, practical approaches, and examples. Preface.
    Kuo LC
    Methods Enzymol; 2011; 493():xxi-xxii. PubMed ID: 21371584
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug discovery and the medicinal chemist.
    Maryanoff BE
    Future Med Chem; 2009 Apr; 1(1):11-5. PubMed ID: 21426067
    [No Abstract]   [Full Text] [Related]  

  • 13. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract]   [Full Text] [Related]  

  • 14. Label-free technologies and pharmacology.
    Fang Y
    Pharmacol Res; 2016 Jun; 108():88-89. PubMed ID: 27155057
    [No Abstract]   [Full Text] [Related]  

  • 15. Concise review: a high-content screening approach to stem cell research and drug discovery.
    Xia X; Wong ST
    Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The holistic integration of virtual screening in drug discovery.
    Tanrikulu Y; Krüger B; Proschak E
    Drug Discov Today; 2013 Apr; 18(7-8):358-64. PubMed ID: 23340112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural products as catalysts for innovation: a pharmaceutical industry perspective.
    Schmitt EK; Moore CM; Krastel P; Petersen F
    Curr Opin Chem Biol; 2011 Aug; 15(4):497-504. PubMed ID: 21684800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the use of CROs by academia and small companies.
    Lane RF; Friedman LG; Keith C; Braithwaite SP; Frearson JA; Lowe DA; Longo FM; Refolo LM; Watterson DM; Tsaioun K; Shineman DW; Fillit HM
    Nat Rev Drug Discov; 2013 Jul; 12(7):487-8. PubMed ID: 23812255
    [No Abstract]   [Full Text] [Related]  

  • 20. Discovery of a new drug--from target identification to ultra-high-throughput screening.
    Golz S; Hüser J
    Clin Lab; 2007; 53(1-2):77-9. PubMed ID: 17323829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.